305 related articles for article (PubMed ID: 17302780)
1. A possible role for the production of multiple HLA antibodies in fatal platelet transfusion refractoriness after peripheral blood progenitor cell transplantation from the mother in a patient with relapsed leukemia.
Nakazawa Y; Saito S; Hasegawa Y; Yanagisawa R; Sakashita K; Kamijo T; Miyazaki T; Sato S; Ikeda H; Ikebuchi K; Koike K
Transfusion; 2007 Feb; 47(2):326-34. PubMed ID: 17302780
[TBL] [Abstract][Full Text] [Related]
2. Platelet transfusion refractoriness attributable to HLA antibodies produced by donor-derived cells after allogeneic bone marrow transplantation from one HLA-antigen-mismatched mother.
Hatakeyama N; Hori T; Yamamoto M; Inazawa N; Iesato K; Miyazaki T; Ikeda H; Tsutsumi H; Suzuki N
Pediatr Transplant; 2011 Dec; 15(8):E177-82. PubMed ID: 20880381
[TBL] [Abstract][Full Text] [Related]
3. [Platelet alloimmunization in patients with oncologic blood disorders treated with multiple transfusions: prospective study in adults and children].
Pereira J; Bronfman L; Bertín P; Marzouka E; Hidalgo P; Amaya S; Mezzano D
Rev Med Chil; 1997 Nov; 125(11):1305-12. PubMed ID: 9609051
[TBL] [Abstract][Full Text] [Related]
4. Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation.
Toor AA; Choo SY; Little JA
Bone Marrow Transplant; 2000 Aug; 26(3):315-20. PubMed ID: 10967572
[TBL] [Abstract][Full Text] [Related]
5. Platelet alloimmunization after long-term red cell transfusion in transfusion-dependent thalassemia patients.
Lo SC; Chang JS; Lin SW; Lin DT
Transfusion; 2005 May; 45(5):761-5. PubMed ID: 15847666
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
7. [Emergence of donor-derived anti-HLA antibody and subsequent transfusion-refractory thrombocytopenia after allogeneic hematopoietic stem cell transplantation from an HLA-matched sibling donor in a patient with acute myeloid leukemia].
Uchiyama Y; Hoshino T; Mihara M; Mitsui T; Koiso H; Takizawa M; Yokohama A; Saitoh T; Uchiumi H; Handa H; Tsukamoto N; Murakami H; Nojima Y
Rinsho Ketsueki; 2013 Feb; 54(2):214-8. PubMed ID: 23470830
[TBL] [Abstract][Full Text] [Related]
8. Generation of HLA-deficient platelets from hematopoietic progenitor cells.
Figueiredo C; Goudeva L; Horn PA; Eiz-Vesper B; Blasczyk R; Seltsam A
Transfusion; 2010 Aug; 50(8):1690-701. PubMed ID: 20412529
[TBL] [Abstract][Full Text] [Related]
9. Pretransplant platelet transfusion refractoriness is not associated with platelet nonengraftment in T-replete hematopoietic progenitor cell transplantation for hematologic malignancies.
Scott A; Baidya S; Butler J; Morris K; Thornton A; Kennedy GA
Transfusion; 2016 Jan; 56(1):164-9. PubMed ID: 26264674
[TBL] [Abstract][Full Text] [Related]
10. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
[TBL] [Abstract][Full Text] [Related]
11. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
12. Generation of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions.
Sakagawa H; Miyazaki T; Fujihara M; Sato S; Yamaguchi M; Fukai K; Morioka M; Kato T; Azuma H; Ikeda H
Transfusion; 2007 Jan; 47(1):154-61. PubMed ID: 17207244
[TBL] [Abstract][Full Text] [Related]
13. Human platelet alloantigens.
Santoso S; Kiefel V
Wien Klin Wochenschr; 2001 Oct; 113(20-21):806-13. PubMed ID: 11732116
[TBL] [Abstract][Full Text] [Related]
14. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
[TBL] [Abstract][Full Text] [Related]
15. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
[TBL] [Abstract][Full Text] [Related]
16. Genetically engineered blood pharming: generation of HLA-universal platelets derived from CD34+ progenitor cells.
Figueiredo C; Blaszczyk R
J Stem Cells; 2014; 9(3):149-61. PubMed ID: 25157449
[TBL] [Abstract][Full Text] [Related]
17. Neonatal alloimmune thrombocytopenia due to anti-human leukocyte antigen antibody: a case report.
Sasaki M; Yagihashi A; Kobayashi D; Watanabe N; Fujikawa T; Chiba S; Sato S; Morishita K; Sekimoto T; Ikeda H
Pediatr Hematol Oncol; 2001 Dec; 18(8):519-24. PubMed ID: 11764101
[TBL] [Abstract][Full Text] [Related]
18. Platelets do not adsorb HLA class I molecules during storage of pooled platelet concentrates.
Zeiler T; Heim M; Dempfle A; Kretschmer V
Transfus Med; 2006 Jun; 16(3):176-83. PubMed ID: 16764596
[TBL] [Abstract][Full Text] [Related]
19. Graft rejection and hyperacute graft-versus-host disease in stem cell transplantation from non-inherited maternal-antigen-complementary HLA-mismatched siblings.
Okumura H; Yamaguchi M; Kotani T; Sugimori N; Sugimori C; Ozaki J; Kondo Y; Yamazaki H; Chuhjo T; Takami A; Ueda M; Ohtake S; Nakao S
Eur J Haematol; 2007 Feb; 78(2):157-60. PubMed ID: 17313562
[TBL] [Abstract][Full Text] [Related]
20. Donor-specific anti-human leukocyte antigen class I antibodies after implantation of cardiac valve allografts.
Hoekstra F; Witvliet M; Knoop C; Akkersdijk G; Jutte N; Bogers A; Claas F; Weimar W
J Heart Lung Transplant; 1997 May; 16(5):570-2. PubMed ID: 9171278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
